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Abstract 
Background: Post-prandial hyperglycemia is associated with higher cardiovascular risk, 
which causes arterial stiffening and impaired function. Although post-prandial increases in 
blood glucose are proportional to the level of intake, the acute effects of different glucose 
intakes on arterial stiffness have not been fully characterized. The present study aimed to 
determine the acute effects of differences in glucose intake on arterial stiffness.  
Methods: Six healthy middle-aged and elderly individuals (mean age, 60.0 ± 12.1 years) 
were orally administered 15, 20, and 25 g of glucose on separate days in a randomized, 
controlled, cross-over fashion. Brachial-ankle pulse wave velocity, heart-brachial pulse wave 
velocity, cardio-ankle vascular index, brachial and ankle blood pressure, heart rate, and blood 
glucose and serum insulin concentrations before and 30, 60, and 90 min after glucose 
ingestion were measured. 
Results: Compared to baseline, brachial-ankle pulse wave velocity was higher at 30, 60 and 
90 min after ingestion of 25 g glucose, and higher at 90 min after ingestion of 20 g glucose, 
 but at no time points after ingestion of 15 g. Cardio-ankle vascular index was higher at 60 
min than at baseline after ingestion of 25 g glucose, but not after ingestion of 15 or 20 g. 
Conclusions: These results suggest that brachial-ankle pulse wave velocity and cardio-ankle 
vascular index is affected by the quantity of glucose ingested. Proposed presently is that 
glucose intake should be reduced at each meal to avoid increases in brachial-ankle pulse 
wave velocity and cardio-ankle vascular index during acute hyperglycemia. 
Key words: arterial stiffness, brachial-ankle pulse wave velocity, cardio-ankle vascular 
index, quantity of glucose ingestion, healthy subjects 
 
 
INTRODUCTION 
High central (aortic), peripheral (leg) and systemic pulse wave velocity (PWV) and 
cardio-ankle vascular index (CAVI) are indices of arterial stiffness and are used as important 
determinants and indices of cardiovascular risk [1, 2]. Moreover, high ankle systolic blood 
pressure (SBP) has been proposed as an independent risk factor for the development of 
cardiovascular disease [3]. Wohlfahrt et al. [4] reported that arterial stiffness correlates with 
ankle SBP. Inhibition of any increases in arterial stiffness and ankle SBP might thus be 
beneficial for health. 
Arterial stiffness and ankle SBP acutely increase after glucose ingestion [5, 6], and 
higher post-prandial hyperglycemia is associated with cardiovascular risk, which causes 
arterial stiffening and impaired functioning [7]. Furthermore, a new World Health 
Organization (WHO) guideline recommends that adults and children reduce the daily intake 
of free sugars to < 25 g [8]. Although post-prandial increases in blood glucose (BG) are 
known to be proportional to the level of intake [9], whether arterial stiffness and SBP will 
increase after ingesting < 25 g of glucose remains unclear.  
The present study aimed to investigate the acute effects of differences in glucose 
intake on arterial stiffness and SBP. Hypothesized herein is that differences in glucose intake 
would affect changes in arterial stiffness and SBP after glucose ingestion in older adults. 
 
METHODS 
Subjects 
In this study there are 6 healthy subjects (mean age, 60 ± 12 years). All lived a 
sedentary lifestyle (≥ 2 years without regular exercise as assessed by the international 
physical activity questionnaire) and were normotensive (< 140/90 mmHg), normoglycemia (< 
 109 mg/dL), non-smokers, without symptoms or history of overt chronic disease (Table 1). 
All participants were fully informed about the experimental procedures as well as the purpose 
of the study before providing written, informed consent to participate. The Ethics Committee 
at Teikyo University of Science approved this study, which proceeded in accordance with the 
guidelines for human experimentation published by the documented institutional review 
board (approval no. 18034). This study also conformed to the principles of the Declaration of 
Helsinki. 
 
Study design 
Each participant completed 3 trials in random order: orally administered 15, 20, and 
25 g glucose (in 200 mL of water, consumed within 5 min) on separate days. All subjects 
then rested for at least 10 min in a supine position to establish a stable baseline. Each 
volunteer waited about 2–3 days after completion of one trial before crossing over to the next 
trial. Brachial-ankle PWV was measured, (baPWV indicative of systemic arterial stiffness), 
heart-brachial PWV (hbPWV, indicative of proximal aortic arterial stiffness), brachial and 
ankle SBP, diastolic BP (DBP), pulse pressure (PP), heart rate (HR), CAVI (indicative of 
systemic arterial stiffness), and BG and serum insulin concentrations, before (baseline) and 
30, 60, and 90 min after glucose ingestion. All these measurements, including baPWV, 
hbPWV, CAVI, and fasting blood glucose, were evaluated after 12 h of fasting (Fig. 1).  
 
Anthropometrics 
Height and weight were measured to the nearest 0.5 cm using a stadiometer, and 
body composition was determined using a body composition analyzer (WB-150 PMA; 
TANITA Co., Tokyo, Japan). 
 
Arterial stiffness 
baPWV, hbPWV, BP, and HR was measured using a Form PWV/ABI vascular 
testing device [10] (Fukuda-Colin Co., Tokyo, Japan) and CAVI using a VaSera VS-1500® 
vascular testing device [11] (Fukuda Denshi Co., Tokyo, Japan). baPWV is an index that 
reflects systemic arterial stiffness and hbPWV reflects proximal aortic stiffness. The CAVI is 
an index that reflects systemic arterial stiffness is theoretically adjusted by blood pressure. 
 
Blood pressure and heart rate 
 Brachial and ankle SBP, mean BP (MBP) and DBP, PP and HR while in supine 
resting were measured in triplicate using an automated oscillometric-form PWV/ABI device 
(Form PWV/ABI; Fukuda-Colin Co., Tokyo, Japan) over the brachial and ankle arteries. 
Carotid SBP, which has been proposed as an indicator of the magnitude of wave reflections, 
was also obtained from pressure waveforms [12]. 
 
Blood glucose and insulin levels 
Venous blood was withdrawn from participants via catheter in the right or left arm 
before, and at 30, 60 and 90 min after ingestion of 15, 20 or 25 g glucose. Levels of BG and 
insulin were assayed using the ultraviolet-hexokinase method and chemiluminescent enzyme 
immunoassay, respectively. 
 
Oral glucose ingestion 
15, 20, and 25 g of glucose were orally administered to each participant (in 200 mL 
of water, consumed within 5 min) on separate days using a cross-over design in the morning 
after an overnight (12 h) fast. The glucose beverage (200 mL) was within the standard for 
adult humans and was consumed within 5 min [13]. 
 
Sample size 
A power analysis was performed with G*Power 3 to determine the appropriate 
sample size. Effect size for arterial stiffness at the laboratory was 0.5. To detect differences 
with 60% power and a one-tailed α of 5% in the laboratory using analysis of variance, it was 
calculated that each intervention would require 6 individuals. 
 
Statistical analyses 
All data are presented as mean ± standard deviation (SD). The normal distribution of 
all data was conﬁrmed using the Kolmogorov-Smirnov test. Data were analyzed using 
repeated-measures two-way analysis of variance, with variables of group and time. 
Significant differences between mean values were identified using the Bonferroni post-test. 
Data were analyzed using SPSS version 25 (IBM, Armonk, NY), with statistical significance 
being accepted at the level of p < 0.05. 
 
RESULTS 
 Baseline baPWV, hbPWV, and CAVI did not differ between trials (p > 0.05, Fig. 2). 
The baPWV was higher at 30, 60 and 90 min than at baseline after ingestion of 25 g glucose 
trial (p < 0.05, Fig. 2A), and significantly higher at 90 min than at baseline after ingestion of 
20 g glucose trial (p < 0.05, Fig. 2A), but no significant changes were seen after ingestion of 
15 g glucose trial (p > 0.05, Fig. 2A). The hbPWV was no different at 30, 60, or 90 min than 
at baseline after ingestion of any quantity of glucose (p > 0.05, Fig. 2B). CAVI was 
significantly higher at 60 min than at baseline after ingestion of 25 g glucose trial (p < 0.05, 
Fig. 2C), but no significant differences were seen following the 15 or 20 g trial (p > 0.05, Fig. 
2C). 
Brachial SBP, DBP and PP and ankle DBP did not differ significantly according to 
glucose dose (p > 0.05 each, Table 2). Brachial SBP, DBP and PP and ankle DBP were not 
significantly different at 30, 60 or 90 min than at baseline after ingesting any quantity of 
glucose (p > 0.05 each, Table 2). Ankle SBP was significantly higher at 30, 60 and 90 min 
than at baseline after ingestion of 25 g glucose trial (p < 0.05, Table 2), and at 60 and 90 min 
after ingestion of 20 g glucose trial (p < 0.05, Table 2), but no significant differences were 
seen following the ingestion of 15 g glucose trial (p > 0.05, Table 2). Ankle PP was 
significantly higher at 60 and 90 min than at baseline after ingestion of 20 and 25 g glucose 
trial (p < 0.05, Table 2), but no significant differences were seen following ingestion of 15 g 
glucose trial (p > 0.05, Table 2).  
Blood glucose was significantly higher at 60 min after the ingestion in the ingestion 
of 20 or 25 g glucose compared with the ingestion of 15 g glucose trial (p < 0.05, Table 3). 
Compared to baseline, BG was significantly higher at 30 min after ingestion of 15 g glucose 
trial (p < 0.05, Table 3), at 30 and 60 min after ingestion of 20 g glucose trial (p < 0.05, Table 
3), and at 30, 60, and 90 min after ingestion of 25 g (p < 0.05, Table 3). Compared to 
baseline, Serum insulin was significantly higher at 30 min after ingestion of 15 g glucose trial 
(p < 0.05, Table 3), at 60 and 90 min after 20 g (p < 0.05, Table 3), and at 30, 60, and 90 min 
than at baseline after 25 g glucose trial (p < 0.05, Table 3). 
 
DISCUSSION 
The novel finding of this study was that baPWV and CAVI were significantly 
increased after ingestion of 25 g glucose, and baPWV was significantly increased after 
ingestion of 20 g glucose, but not after ingestion of 15 g. These results suggest that baPWV 
and CAVI only increase after larger doses of glucose. It was therefore proposed that glucose 
 intake in a single meal should be reduced to prevent significant post-prandial increases in 
arterial stiffness. 
Arterial stiffness acutely increases following high-carbohydrate meals. Indeed, 
Grassi et al. [14] and Gomez-Sanchez et al. [15] reported that systemic and peripheral arterial 
stiffness increased after glucose ingestion in healthy volunteers. Higher cardiovascular risk is 
associated with post-prandial hyperglycemia, which causes arterial stiffening [7]. The current 
WHO guideline recommends that adults and children reduce the daily intake of free sugars to 
< 25 g [8]. It was shown that baPWV was significantly higher at 30, 60 and 90 min than at 
baseline after ingestion of 25 g glucose, and was significantly higher at 90 min than at 
baseline after ingestion of 20 g glucose, whereas no significant change was seen after 
ingestion of 15 g. Thus, consuming drinks and meals with lower sugar content might be 
effective in reducing the amount of glucose ingested at a single sitting, and thus suppress the 
increase in arterial stiffness that follows glucose ingestion. In addition, future research should 
use a method that does not increase arterial stiffness because of high-dose glucose ingestion, 
such as by changing from the use of glucose to palatinose. 
Aortic arterial stiffness increases after glucose ingestion in obese individuals and 
those with metabolic syndrome [16]. It was previously reported that leg PWV increases 
acutely, whereas aortic PWV does not change, after oral ingestion of 75 g glucose in healthy 
individuals [5, 17]. Current findings indicate that both baPWV and CAVI significantly 
increase after ingestion of 25 g glucose, and baPWV significantly increases after ingestion of 
20 g of glucose, whereas hbPWV (an indicator of proximal aortic stiffness) is unaffected by 
ingestion of 15–25 g glucose in healthy older individuals. The increase in arterial stiffness 
after ingestion of glucose might thus be stronger in the lower limb artery than in the aorta. 
However, changes in aortic PWV after glucose ingestion might occur in obese older 
individuals (those with high insulin resistance). 
Greater arterial stiffness after meals is associated with increases in SBP [5, 18]. It 
was shown herein, that hbPWV and brachial SBP were not significantly changed after 
ingestion of glucose. The present study shows that baPWV and ankle SBP increased after 
ingestion of glucose. It was previously reported that leg PWV and ankle SBP increased 
acutely, whereas aortic PWV and aortic SBP did not change significantly, after oral ingestion 
of 75 g glucose in healthy individuals [5, 18]. This rise in ankle SBP may be indicative of an 
increase in baPWV (the main is leg PWV) after ingestion of 20 and 25 g glucose. However, 
this was not directly assessed, representing an important limitation of this study. Importantly, 
it was shown that CAVI increased significantly after ingestion of 25 g glucose. CAVI is 
 independent of blood pressure variations during measurement [19]. The level of oxidative 
stress, as determined by measuring thiobarbituric acid reactive substances (TBARS), acutely 
increases after a 75-g oral glucose tolerance test [20], and Kawano et al. [20] have shown that 
TBARS after glucose ingestion correlates with BG. Chotimol et al. [21] have shown that 
TBARS correlates with CAVI. Thus, the increase in CAVI after ingesting 25 g glucose might 
be associated with oxidative stress induced by hyperglycemia. However, levels of oxidative 
stress were not assessed, representing another limitation of the present study.  
From the above context, it was considered that increased arterial stiffness after 
ingesting 20 g of glucose was mainly related to elevated SBP. Moreover, increased arterial 
stiffness after ingesting 25 g of glucose might be associated with decreased vascular 
endothelial function due to increased oxidative stress and a rise in SBP. Studying the 
mechanisms underlying increases in arterial stiffness due to differences in glucose intake will 
be important in future research. 
 
Limitations of the study 
Some other limitations must be addressed when considering the present findings. 
The participants were healthy subjects, which precludes the generalization of our findings to 
younger individuals. In addition, the sample size was very small (n = 6), although the effects 
of glucose dose on arterial stiffness differed sufficiently in detecting significant differences 
and the differences identified were similar to those identified in previous studies (n = 6) of 
acute changes in arterial stiffness [21]. There was also no control group. A further limitation 
is the lack of carotid-femoral PWV which is the gold standard technique for the assessment 
of arterial stiffness. Finally, this study was not designed to determine the possible 
mechanisms underlying the acute effects of glucose intake on PWV and CAVI. 
 
CONCLUSIONS 
Significant increases in baPWV and CAVI were identified after ingestion of 25 g 
glucose, and baPWV significantly increased after ingestion of 20 g glucose, but neither 
increased after 15 g of glucose. This suggests that arterial stiffness is only acutely affected by 
the ingestion of larger quantities of glucose. It was therefore proposed that glucose intake 
should be reduced at each meal to avoid increases in arterial stiffness during acute 
hyperglycemia. 
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Table 1. Characteristics of study participants. 
 Value 
Age [years] 60 ± 12 
Height [cm] 165 ± 11 
Weight [kg] 62 ± 14 
Body fat [%] 24 ± 4 
BMI [kg/m2] 22 ± 2 
Brachial SBP [mmHg] 120 ± 20 
Ankle SBP [mmHg] 141 ± 11 
BG [mg/dL] 94 ± 9 
Insulin [mg/dL] 5 ± 3 
HDL-C [mg/dL] 58 ± 7 
Triglycerides [mg/dL] 97 ± 25 
Values represent mean ± standard deviation; BMI — 
body mass index; BG — blood glucose; HDL-C — high-
density lipoprotein cholesterol; SBP — systolic blood 
pressure 
  
 Table 2. Changes in cardiovascular indices before and after glucose ingestion. 
 Baseline After 30 min After 60 min After 90 min 
Brachial systolic blood pressure [mmHg] 
15 g glucose ingestion 120 ± 20 118 ± 12 120 ± 16 122 ± 17 
20 g glucose ingestion 118 ± 16 119 ± 15 123 ± 14 125 ± 20 
25 g glucose ingestion 119 ± 17 120 ± 15 123 ± 14 121 ± 17 
Brachial diastolic blood pressure [mmHg] 
15 g glucose ingestion 76 ± 15 75 ± 10 76 ± 10 78 ± 9 
20 g glucose ingestion 75 ± 14 75 ± 11 79 ± 10 80 ± 13 
25 g glucose ingestion 75 ± 15 78 ± 11 76 ± 11 77 ± 12 
Brachial pulse pressure [mmHg] 
15 g glucose ingestion 44 ± 6 42 ± 4 43 ± 8 44 ± 10 
20 g glucose ingestion 42 ± 4 44 ± 7 43 ± 5 45 ± 8 
25 g glucose ingestion 44 ± 4 42 ± 8 46 ± 5 43 ± 5 
Ankle systolic blood pressure [mmHg] 
15 g glucose ingestion 141 ± 11 141 ± 9 141 ± 9 146 ± 9 
20 g glucose ingestion 140 ± 10 144 ± 10 152 ± 11** 151 ± 12** 
25 g glucose ingestion 139 ± 11 147 ± 9* 153 ± 10** 151 ± 10** 
Ankle diastolic blood pressure [mmHg] 
15 g glucose ingestion 76 ± 15 75 ± 10 76 ± 11 77 ± 9 
20 g glucose ingestion 76 ± 11 76 ± 13 80 ± 11 80 ± 13 
25 g glucose ingestion 76 ± 12 78 ± 12 78 ± 10 78 ± 15 
Ankle pulse pressure [mmHg] 
15 g glucose ingestion 65 ± 13 65 ± 12 64 ± 15 68 ± 15 
20 g glucose ingestion 64 ± 14 68 ± 16 71 ± 17* 71 ± 17* 
25 g glucose ingestion 62 ± 16 68 ± 12 74 ± 16** 72 ± 11** 
Heart rate [beats/min] 
15 g glucose ingestion 62 ± 9 60 ± 8 59 ± 8 62 ± 10 
20 g glucose ingestion 63 ± 9 59 ± 7 60 ± 7 58 ± 7 
  
  
25 g glucose ingestion 62 ± 9 60 ± 10 62 ± 9 59 ± 8 
Values are mean ± standard deviation. *P < 0.05 vs. baseline; **P < 0.01 vs. baseline 
  
  
Table 3. Changes in blood glucose and insulin levels before and after glucose ingestion. 
 Baseline After 30 min After 60 min After 90 min 
Blood glucose [mg/dL]     
15 g glucose ingestion 94 ± 9 130 ± 28** 108 ± 17 94 ± 17 
20 g glucose ingestion 98 ± 5 139 ± 21** 137 ± 26**, † 110 ± 20 
25 g glucose ingestion 93 ± 12 142 ± 21** 137 ± 26**, † 107 ± 20** 
Insulin [mg/dL]     
15 g glucose ingestion 5 ± 3 11 ± 9* 9 ± 5 6 ± 5 
20 g glucose ingestion 5 ± 2 10 ± 4 15 ± 8** 9 ± 2** 
25 g glucose ingestion 5 ± 2 13 ± 8* 13 ± 5** 9 ± 2** 
Values represent mean ± standard deviation. *P < 0.05 vs. baseline; **P < 0.01 vs. baseline; †P < 0.05 vs. 15 g glucose 
ingestion 
 Figure 1. Study design. After 10 min of supine rest, pulse wave velocity, cardio-ankle 
vascular index, brachial and ankle blood pressure, heart rate, blood glucose level and blood 
insulin level were measured before (baseline) and at 30, 60 and 90 min after glucose 
ingestion (15, 20 and 25 g). 
 
Figure 2. Changes in pulse wave velocity and cardio-ankle vascular index before (baseline) 
and after glucose ingestion. Values represent mean ± standard deviation (SD); baPWV: 
brachial-ankle pulse wave velocity; hbPWV: heart-brachial pulse wave velocity; CAVI: 
cardio-ankle vascular index; *p < 0.05 vs. baseline; **p < 0.01 vs. baseline. 
 


